Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma

The rapid development and remarkable success of checkpoint inhibitors have provided significant breakthroughs in cancer treatment, including hepatocellular carcinoma (HCC). However, only 15-20% of HCC patients can benefit from checkpoint inhibitors. Cancer stem cells (CSCs) are responsible for recur...

Full description

Saved in:
Bibliographic Details
Published in:Theranostics
Main Authors: Dai, Xiaomeng, Guo, Yixuan, Hu, Yan, Bao, Xuanwen, Zhu, Xudong, Fu, Qihan, Zhang, Hangyu, Tong, Zhou, Liu, Lulu, Zheng, Yi, Zhao, Peng, Fang, Weijia
Format: Artigo
Language:Inglês
Published: Ivyspring International Publisher 2021
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7847682/
https://ncbi.nlm.nih.gov/pubmed/33537099
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.54648
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items